Groups Float Tax Credits, New CMS Pay Policies To Stem Drug Shortages

Groups Float Tax Credits, New CMS Pay Policies To Stem Drug Shortages-insidehealthpolicy: A slew of healthcare organizations coalesced around more than a dozen long-term solutions to address drug shortages, including possible use of corporate tax credits to incentivize firms that maintain quality programs, new CMS payment policies and Biomedical Advanced Research and Development Authority models, according to a newly released rundown of a 2013 summit on the issue.